Dual selective iron chelating probes with a potential to monitor mitochondrial labile iron pools

被引：26
|
作者：
Abbate, Vincenzo [1 ]
Reelfs, Olivier [2 ]
Kong, Xiaole [1 ]
Pourzand, Charareh [2 ]
Hider, Robert C. [1 ]
机构：
[1] Kings Coll London, Inst Pharmaceut Sci, London SE1 9NH, England
[2] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England
来源：
CHEMICAL COMMUNICATIONS | 2016年 / 52卷 / 04期
基金：
英国生物技术与生命科学研究理事会;
关键词：
PEPTIDE ANTIOXIDANTS; OXIDATIVE STRESS; ULTRAVIOLET; RADIATION; DISEASE; DESIGN;
D O I：
10.1039/c5cc06170a
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
Mitochondria-targeted peptides incorporating dual fluorescent and selective iron chelators have been designed as novel biosensors for the mitochondrial labile iron pool. The probes were demonstrated to specifically co-localize with mitochondria and their fluorescence emission was found to be sensitive to the presence of iron.
引用
收藏
页码：784 / 787
页数：4
相关论文
共 50 条
  • [31] Characterization of the Neuroprotective Potential of Derivatives of the Iron Chelating Drug Deferiprone
    Maher, Pamela
    Kontoghiorghes, George J.
    NEUROCHEMICAL RESEARCH, 2015, 40 (03) : 609 - 620
  • [32] Antioxidant Potential and Iron Chelating Activity of Some Bioactive Compounds
    Babri, Rauf Attique
    Khokhar, Irshad
    Mahmud, Shahid
    JOURNAL OF THE CHEMICAL SOCIETY OF PAKISTAN, 2015, 37 (03): : 514 - 519
  • [33] HBED: A potential alternative to deferoxamine for iron-chelating therapy
    Bergeron, RJ
    Wiegand, J
    Brittenham, GM
    BLOOD, 1998, 91 (04) : 1446 - 1452
  • [34] MECHANISM OF BINDING OF IRON TO POTENTIAL THERAPEUTIC CHELATING-AGENTS
    SPINGARN, NE
    SARTORELLI, AC
    INTERNATIONAL JOURNAL OF QUANTUM CHEMISTRY, 1980, 18 (02) : 493 - 500
  • [35] The iron-chelating potential of silybin in patients with hereditary haemochromatosis
    Hutchinson, C.
    Bomford, A.
    Geissler, C. A.
    EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2010, 64 (10) : 1239 - 1241
  • [36] The iron-chelating potential of silybin in patients with hereditary haemochromatosis
    C Hutchinson
    A Bomford
    C A Geissler
    European Journal of Clinical Nutrition, 2010, 64 : 1239 - 1241
  • [37] Characterization of the Neuroprotective Potential of Derivatives of the Iron Chelating Drug Deferiprone
    Pamela Maher
    George J. Kontoghiorghes
    Neurochemical Research, 2015, 40 : 609 - 620
  • [38] Mitochondria-penetrating peptides conjugated to desferrioxamine as chelators for mitochondrial labile iron
    Alta, Roxana Y. P.
    Vitorino, Hector A.
    Goswami, Dibakar
    Liria, Cleber W.
    Wisnovsky, Simon P.
    Kelley, Shana O.
    Machini, M. Teresa
    Esposito, Breno P.
    PLOS ONE, 2017, 12 (02):
  • [39] Investigation into Iron Chelating and Antioxidant Potential of Melilotus officinalis in Iron Dextran Induced Iron Overloaded Sprague Dawley Rat Model
    Sheikh, N. A.
    Desai, T. R.
    Tirgar, P. R.
    DRUG RESEARCH, 2016, 66 (12) : 618 - 627
  • [40] Arene-based fluorescent probes for the selective detection of iron
    Kumar, Pramod
    Kumar, Vijay
    Gupta, Rajeev
    RSC ADVANCES, 2015, 5 (118) : 97874 - 97882
12345